Literature DB >> 25787178

An antibody fragment functionalized dendritic PEGylated poly(2-(dimethylamino)ethyl diacrylate) as a vehicle of exogenous microRNA.

M Monaghan1, U Greiser, H Cao, W Wang, A Pandit.   

Abstract

The translation of interfering RNA to the clinic requires more effective delivery agents to enable safe and efficient delivery. The aim of this work was to create a multi-functional delivery agent using deactivation enhanced ATRP synthesis of poly(dimethylamino)ethyl methacrylate (pDMAEMA)-co-PEGMEA/PEGDA (pD-b-P/DA) with linear pDMAEMA as a macro-initiator. The pD-b-P/DA was characterized for its potential to bind synthetic microRNA mimics to form structures and reacted with antibody-derived fragments (Fabs) using Michael-type addition. Conjugation of antibody fragments was verified using SDS-PAGE. Functional delivery of these interfering RNA complexes was proven using a dual luciferase reporter assay. Functional silencing of a reporter gene was improved by complexation of microRNA mimics with pD-b-P/DA alone and with Fab-decorated pD-b-P/DA. The improved silencing with Fab-decorated pD-b-P/DA was evident at 48 h but disappeared at 96 h. The resultant agent enables complexation of nucleic acid (microRNA mimic) and facile conjugation of antibody fragments via a Michael-type addition. In conclusion, this platform is effective at silencing in this reporter system and has potential as an effective delivery system of interfering RNA.

Entities:  

Year:  2012        PMID: 25787178     DOI: 10.1007/s13346-012-0097-8

Source DB:  PubMed          Journal:  Drug Deliv Transl Res        ISSN: 2190-393X            Impact factor:   4.617


  19 in total

Review 1.  Development trends for human monoclonal antibody therapeutics.

Authors:  Aaron L Nelson; Eugen Dhimolea; Janice M Reichert
Journal:  Nat Rev Drug Discov       Date:  2010-09-03       Impact factor: 84.694

Review 2.  RNA interference therapy via functionalized scaffolds.

Authors:  Michael Monaghan; Abhay Pandit
Journal:  Adv Drug Deliv Rev       Date:  2011-01-15       Impact factor: 15.470

3.  A highly effective gene delivery vector--hyperbranched poly(2-(dimethylamino)ethyl methacrylate) from in situ deactivation enhanced ATRP.

Authors:  Ben Newland; Hongyun Tai; Yu Zheng; Diego Velasco; Andrea Di Luca; Steven M Howdle; Cameron Alexander; Wenxin Wang; Abhay Pandit
Journal:  Chem Commun (Camb)       Date:  2010-06-01       Impact factor: 6.222

4.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles.

Authors:  Mark E Davis; Jonathan E Zuckerman; Chung Hang J Choi; David Seligson; Anthony Tolcher; Christopher A Alabi; Yun Yen; Jeremy D Heidel; Antoni Ribas
Journal:  Nature       Date:  2010-03-21       Impact factor: 49.962

5.  Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis.

Authors:  Yu-Hung Huang; Yunhua Bao; Weidan Peng; Michael Goldberg; Kevin Love; David A Bumcrot; Geoffrey Cole; Robert Langer; Daniel G Anderson; Janet A Sawicki
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-10       Impact factor: 11.205

Review 6.  Lentiviral delivery of short hairpin RNAs.

Authors:  N Manjunath; Haoquan Wu; Sandesh Subramanya; Premlata Shankar
Journal:  Adv Drug Deliv Rev       Date:  2009-03-31       Impact factor: 15.470

7.  Engineering of cysteine residues leads to improved production of a human dipeptidase enzyme in E. coli.

Authors:  Ronan O'Dwyer; Rafia Razzaque; Xuejun Hu; Susan K Hollingshead; J Gerard Wall
Journal:  Appl Biochem Biotechnol       Date:  2008-10-17       Impact factor: 2.926

8.  Upregulated expression of miR-1/miR-206 in a rat model of myocardial infarction.

Authors:  Zhi-Xin Shan; Qiu-Xiong Lin; Yong-Heng Fu; Chun-Yu Deng; Zhi-Ling Zhou; Jie-Ning Zhu; Xiao-Ying Liu; You-Yi Zhang; Yangxin Li; Shu-Guang Lin; Xi-Yong Yu
Journal:  Biochem Biophys Res Commun       Date:  2009-02-24       Impact factor: 3.575

9.  miR-22 represses cancer progression by inducing cellular senescence.

Authors:  Dan Xu; Fumitaka Takeshita; Yumiko Hino; Saori Fukunaga; Yasusei Kudo; Aya Tamaki; Junko Matsunaga; Ryou-U Takahashi; Takashi Takata; Akira Shimamoto; Takahiro Ochiya; Hidetoshi Tahara
Journal:  J Cell Biol       Date:  2011-04-18       Impact factor: 10.539

10.  The Plk1 inhibitor BI 2536 temporarily arrests primary cardiac fibroblasts in mitosis and generates aneuploidy in vitro.

Authors:  Bo Lu; Hasan Mahmud; Alexander H Maass; Bo Yu; Wiek H van Gilst; Rudolf A de Boer; Herman H W Silljé
Journal:  PLoS One       Date:  2010-09-24       Impact factor: 3.240

View more
  3 in total

1.  Exogenous miR-29B Delivery Through a Hyaluronan-Based Injectable System Yields Functional Maintenance of the Infarcted Myocardium.

Authors:  Michael G Monaghan; Monika Holeiter; Eva Brauchle; Shannon L Layland; Yan Lu; Arjun Deb; Abhay Pandit; Ali Nsair; Katja Schenke-Layland
Journal:  Tissue Eng Part A       Date:  2017-05-22       Impact factor: 3.845

2.  A molecular nanodevice for targeted degradation of mRNA during protein synthesis.

Authors:  Kyung-Ho Lee; Seung-Eui Min; Haseong Kim; Seung-Goo Lee; Dong-Myung Kim
Journal:  Sci Rep       Date:  2016-02-09       Impact factor: 4.379

3.  A hyperbranched dopamine-containing PEG-based polymer for the inhibition of α-synuclein fibrillation.

Authors:  Leonid Breydo; Ben Newland; Hong Zhang; Anne Rosser; Carsten Werner; Vladimir N Uversky; Wenxin Wang
Journal:  Biochem Biophys Res Commun       Date:  2015-12-18       Impact factor: 3.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.